These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 20973328

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium.
    Fraeyman J, Van Hal G, Godman B, Beutels P.
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):141-51. PubMed ID: 23402454
    [Abstract] [Full Text] [Related]

  • 7. Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future.
    Godman B, Burkhardt T, Bucsics A, Wettermark B, Wieninger P.
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):475-84. PubMed ID: 19817531
    [Abstract] [Full Text] [Related]

  • 8. Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi.
    Abuelkhair M, Abdu S, Godman B, Fahmy S, Malmström RE, Gustafsson LL.
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):115-24. PubMed ID: 22280201
    [Abstract] [Full Text] [Related]

  • 9. Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.
    Tran YB, Frial T, Miller PS.
    Can J Clin Pharmacol; 2007 Feb; 14(2):e205-14. PubMed ID: 17556788
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Encouraging generic use can yield significant savings.
    Zimmerman C.
    Find Brief; 2012 Nov; 15(8):1-3. PubMed ID: 23213854
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Evaluation of prescription practices and of the rational use of medicines in Niger].
    Mallet HP, Njikam A, Scouflaire SM.
    Sante; 2001 Nov; 11(3):185-93. PubMed ID: 11641083
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months.
    Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundström A, Westerholm B, Rosén M.
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):726-35. PubMed ID: 16897791
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
    McManus P, Birkett DJ, Dudley J, Stevens A.
    Pharmacoepidemiol Drug Saf; 2001 Jul; 10(4):295-300. PubMed ID: 11760489
    [Abstract] [Full Text] [Related]

  • 19. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.
    Anderson GM, Kerluke KJ, Pulcins IR, Hertzman C, Barer ML.
    Inquiry; 1993 Jul; 30(2):199-207. PubMed ID: 8314608
    [Abstract] [Full Text] [Related]

  • 20. Twenty-Year Nationwide Trends in Statin Utilization and Expenditure in Denmark.
    Mortensen MB, Falk E, Schmidt M.
    Circ Cardiovasc Qual Outcomes; 2017 Jul; 10(7):. PubMed ID: 28698192
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.